The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point-of-Care Glucose Testing Market Research Report 2025

Global Point-of-Care Glucose Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1550624

No of Pages : 97

Synopsis
Glycemic control in hospitalized patients with diabetes requires accurate near-patient glucose monitoring systems.
The global Point-of-Care Glucose Testing market was valued at US$ 11810 million in 2023 and is anticipated to reach US$ 15890 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
North American market for Point-of-Care Glucose Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Point-of-Care Glucose Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Point-of-Care Glucose Testing include Roche Holding AG, Abbott, Nova Biomedical, Prodigy Diabetes Care, Johnson & Johnson, Nipro, ACON Laboratories, Inc., Trividia Health, Inc. and Panasonic Healthcare Holdings, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Glucose Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Glucose Testing.
Report Scope
The Point-of-Care Glucose Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point-of-Care Glucose Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-of-Care Glucose Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Holding AG
Abbott
Nova Biomedical
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
Segment by Type
0.5uL/0.6uL
1uL
1.5uL
Others
Segment by Application
Hospital
Clinic
Household
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Point-of-Care Glucose Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Point-of-Care Glucose Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Point-of-Care Glucose Testing Market Overview
1.1 Product Overview and Scope of Point-of-Care Glucose Testing
1.2 Point-of-Care Glucose Testing Segment by Type
1.2.1 Global Point-of-Care Glucose Testing Market Value Comparison by Type (2024-2030)
1.2.2 0.5uL/0.6uL
1.2.3 1uL
1.2.4 1.5uL
1.2.5 Others
1.3 Point-of-Care Glucose Testing Segment by Application
1.3.1 Global Point-of-Care Glucose Testing Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Global Point-of-Care Glucose Testing Market Size Estimates and Forecasts
1.4.1 Global Point-of-Care Glucose Testing Revenue 2019-2030
1.4.2 Global Point-of-Care Glucose Testing Sales 2019-2030
1.4.3 Global Point-of-Care Glucose Testing Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Point-of-Care Glucose Testing Market Competition by Manufacturers
2.1 Global Point-of-Care Glucose Testing Sales Market Share by Manufacturers (2019-2024)
2.2 Global Point-of-Care Glucose Testing Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Point-of-Care Glucose Testing Average Price by Manufacturers (2019-2024)
2.4 Global Point-of-Care Glucose Testing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Point-of-Care Glucose Testing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Point-of-Care Glucose Testing, Product Type & Application
2.7 Point-of-Care Glucose Testing Market Competitive Situation and Trends
2.7.1 Point-of-Care Glucose Testing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Point-of-Care Glucose Testing Players Market Share by Revenue
2.7.3 Global Point-of-Care Glucose Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-of-Care Glucose Testing Retrospective Market Scenario by Region
3.1 Global Point-of-Care Glucose Testing Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Point-of-Care Glucose Testing Global Point-of-Care Glucose Testing Sales by Region: 2019-2030
3.2.1 Global Point-of-Care Glucose Testing Sales by Region: 2019-2024
3.2.2 Global Point-of-Care Glucose Testing Sales by Region: 2025-2030
3.3 Global Point-of-Care Glucose Testing Global Point-of-Care Glucose Testing Revenue by Region: 2019-2030
3.3.1 Global Point-of-Care Glucose Testing Revenue by Region: 2019-2024
3.3.2 Global Point-of-Care Glucose Testing Revenue by Region: 2025-2030
3.4 North America Point-of-Care Glucose Testing Market Facts & Figures by Country
3.4.1 North America Point-of-Care Glucose Testing Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Point-of-Care Glucose Testing Sales by Country (2019-2030)
3.4.3 North America Point-of-Care Glucose Testing Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Point-of-Care Glucose Testing Market Facts & Figures by Country
3.5.1 Europe Point-of-Care Glucose Testing Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Point-of-Care Glucose Testing Sales by Country (2019-2030)
3.5.3 Europe Point-of-Care Glucose Testing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Point-of-Care Glucose Testing Market Facts & Figures by Country
3.6.1 Asia Pacific Point-of-Care Glucose Testing Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Point-of-Care Glucose Testing Sales by Country (2019-2030)
3.6.3 Asia Pacific Point-of-Care Glucose Testing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Point-of-Care Glucose Testing Market Facts & Figures by Country
3.7.1 Latin America Point-of-Care Glucose Testing Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Point-of-Care Glucose Testing Sales by Country (2019-2030)
3.7.3 Latin America Point-of-Care Glucose Testing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Point-of-Care Glucose Testing Market Facts & Figures by Country
3.8.1 Middle East and Africa Point-of-Care Glucose Testing Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Point-of-Care Glucose Testing Sales by Country (2019-2030)
3.8.3 Middle East and Africa Point-of-Care Glucose Testing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Point-of-Care Glucose Testing Sales by Type (2019-2030)
4.1.1 Global Point-of-Care Glucose Testing Sales by Type (2019-2024)
4.1.2 Global Point-of-Care Glucose Testing Sales by Type (2025-2030)
4.1.3 Global Point-of-Care Glucose Testing Sales Market Share by Type (2019-2030)
4.2 Global Point-of-Care Glucose Testing Revenue by Type (2019-2030)
4.2.1 Global Point-of-Care Glucose Testing Revenue by Type (2019-2024)
4.2.2 Global Point-of-Care Glucose Testing Revenue by Type (2025-2030)
4.2.3 Global Point-of-Care Glucose Testing Revenue Market Share by Type (2019-2030)
4.3 Global Point-of-Care Glucose Testing Price by Type (2019-2030)
5 Segment by Application
5.1 Global Point-of-Care Glucose Testing Sales by Application (2019-2030)
5.1.1 Global Point-of-Care Glucose Testing Sales by Application (2019-2024)
5.1.2 Global Point-of-Care Glucose Testing Sales by Application (2025-2030)
5.1.3 Global Point-of-Care Glucose Testing Sales Market Share by Application (2019-2030)
5.2 Global Point-of-Care Glucose Testing Revenue by Application (2019-2030)
5.2.1 Global Point-of-Care Glucose Testing Revenue by Application (2019-2024)
5.2.2 Global Point-of-Care Glucose Testing Revenue by Application (2025-2030)
5.2.3 Global Point-of-Care Glucose Testing Revenue Market Share by Application (2019-2030)
5.3 Global Point-of-Care Glucose Testing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche Holding AG
6.1.1 Roche Holding AG Corporation Information
6.1.2 Roche Holding AG Description and Business Overview
6.1.3 Roche Holding AG Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Holding AG Point-of-Care Glucose Testing Product Portfolio
6.1.5 Roche Holding AG Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Point-of-Care Glucose Testing Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Nova Biomedical
6.3.1 Nova Biomedical Corporation Information
6.3.2 Nova Biomedical Description and Business Overview
6.3.3 Nova Biomedical Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Nova Biomedical Point-of-Care Glucose Testing Product Portfolio
6.3.5 Nova Biomedical Recent Developments/Updates
6.4 Prodigy Diabetes Care
6.4.1 Prodigy Diabetes Care Corporation Information
6.4.2 Prodigy Diabetes Care Description and Business Overview
6.4.3 Prodigy Diabetes Care Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prodigy Diabetes Care Point-of-Care Glucose Testing Product Portfolio
6.4.5 Prodigy Diabetes Care Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Point-of-Care Glucose Testing Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Nipro
6.6.1 Nipro Corporation Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nipro Point-of-Care Glucose Testing Product Portfolio
6.6.5 Nipro Recent Developments/Updates
6.7 ACON Laboratories, Inc.
6.6.1 ACON Laboratories, Inc. Corporation Information
6.6.2 ACON Laboratories, Inc. Description and Business Overview
6.6.3 ACON Laboratories, Inc. Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ACON Laboratories, Inc. Point-of-Care Glucose Testing Product Portfolio
6.7.5 ACON Laboratories, Inc. Recent Developments/Updates
6.8 Trividia Health, Inc.
6.8.1 Trividia Health, Inc. Corporation Information
6.8.2 Trividia Health, Inc. Description and Business Overview
6.8.3 Trividia Health, Inc. Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Trividia Health, Inc. Point-of-Care Glucose Testing Product Portfolio
6.8.5 Trividia Health, Inc. Recent Developments/Updates
6.9 Panasonic Healthcare Holdings
6.9.1 Panasonic Healthcare Holdings Corporation Information
6.9.2 Panasonic Healthcare Holdings Description and Business Overview
6.9.3 Panasonic Healthcare Holdings Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Panasonic Healthcare Holdings Point-of-Care Glucose Testing Product Portfolio
6.9.5 Panasonic Healthcare Holdings Recent Developments/Updates
6.10 EKF Diagnostics
6.10.1 EKF Diagnostics Corporation Information
6.10.2 EKF Diagnostics Description and Business Overview
6.10.3 EKF Diagnostics Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 EKF Diagnostics Point-of-Care Glucose Testing Product Portfolio
6.10.5 EKF Diagnostics Recent Developments/Updates
6.11 Omron
6.11.1 Omron Corporation Information
6.11.2 Omron Point-of-Care Glucose Testing Description and Business Overview
6.11.3 Omron Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Omron Point-of-Care Glucose Testing Product Portfolio
6.11.5 Omron Recent Developments/Updates
6.12 B. Braun
6.12.1 B. Braun Corporation Information
6.12.2 B. Braun Point-of-Care Glucose Testing Description and Business Overview
6.12.3 B. Braun Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.12.4 B. Braun Point-of-Care Glucose Testing Product Portfolio
6.12.5 B. Braun Recent Developments/Updates
6.13 77 Elektronika
6.13.1 77 Elektronika Corporation Information
6.13.2 77 Elektronika Point-of-Care Glucose Testing Description and Business Overview
6.13.3 77 Elektronika Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.13.4 77 Elektronika Point-of-Care Glucose Testing Product Portfolio
6.13.5 77 Elektronika Recent Developments/Updates
6.14 AgaMatrix
6.14.1 AgaMatrix Corporation Information
6.14.2 AgaMatrix Point-of-Care Glucose Testing Description and Business Overview
6.14.3 AgaMatrix Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AgaMatrix Point-of-Care Glucose Testing Product Portfolio
6.14.5 AgaMatrix Recent Developments/Updates
6.15 Terumo
6.15.1 Terumo Corporation Information
6.15.2 Terumo Point-of-Care Glucose Testing Description and Business Overview
6.15.3 Terumo Point-of-Care Glucose Testing Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Terumo Point-of-Care Glucose Testing Product Portfolio
6.15.5 Terumo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Point-of-Care Glucose Testing Industry Chain Analysis
7.2 Point-of-Care Glucose Testing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Point-of-Care Glucose Testing Production Mode & Process
7.4 Point-of-Care Glucose Testing Sales and Marketing
7.4.1 Point-of-Care Glucose Testing Sales Channels
7.4.2 Point-of-Care Glucose Testing Distributors
7.5 Point-of-Care Glucose Testing Customers
8 Point-of-Care Glucose Testing Market Dynamics
8.1 Point-of-Care Glucose Testing Industry Trends
8.2 Point-of-Care Glucose Testing Market Drivers
8.3 Point-of-Care Glucose Testing Market Challenges
8.4 Point-of-Care Glucose Testing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’